Zehra Akman ilik

Dr. Zehra Akman ilik


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
FAFırat Aslan
Fırat Aslan
SBSerhat Binici
Serhat Binici
IEIKLIL ERYILMAZ
IKLIL ERYILMAZ
BBBurhan Burhan Beger
Burhan Burhan Beger
OBORHAN BEGER
ORHAN BEGER
MKMehmet Cetin Kotan
Mehmet Cetin Kotan
Background/Aim: Anastomotic stricture following choledochojejunostomy (CJS) is largely driven by fibrotic remodeling at the anastomotic site, a process mediated by transforming growth factor-β (TGF-β) signaling. This problem is particularly relevant in emergency biliary surgery, where CJS is frequently performed under suboptimal conditions and anastomotic leakage is common, predisposing to exaggerated fibrosis and late strictures. This study aimed to evaluate the effect of the TGF-β type I receptor (ALK5) inhibitor EW-7197 (vactosertib) on histopathological parameters of anastomotic healing, with a particular focus on fibrosis, in a rat CJS model. Materials and Methods: Twenty-four male Wistar Albino rats were randomized into three groups (n = 8 each): control (G1), CJS only (G2), and CJS plus EW-7197 (G3). EW-7197 was administered as a single intraperitoneal dose (20 mg/kg) immediately after completion of the anastomosis. On postoperative day 21, choledochojejunal anastomotic tissues were harvested and evaluated histologically using hematoxylin–eosin and Masson’s trichrome staining. Edema, hyperemia, inflammation, and fibrosis were graded using a semi-quantitative scoring system, and intergroup comparisons were performed using non-parametric statistical tests. Results: Compared with surgery alone, EW-7197 treatment resulted in a statistically significant reduction in fibrosis severity at the anastomotic site (p < 0.001) and a significant attenuation of hyperemia (p = 0.007). Edema scores showed a downward trend in the EW-7197-treated group but did not reach statistical significance, while inflammation scores did not differ significantly between the surgical groups. Conclusions: In this experimental rat choledochojejunostomy model, administration of the selective ALK5 inhibitor EW-7197 significantly reduced histopathological fibrosis and hyperemia at the anastomotic site on postoperative day 21 without affecting inflammation severity. These findings support the role of the TGF-β/Smad pathway in bilioenteric anastomotic fibrotic remodeling. However, further studies including molecular validation and functional assessments are required to clarify the translational relevance of these results.

5 January 2026 in Current Eye Research
Verified
Journal Article
Closed access
RTRumeysa Bilmez Tan
Rumeysa Bilmez Tan
STSerek Tekin
Serek Tekin
ZIZehra Akman ilik
Zehra Akman ilik
MBMuhammed Batur
Muhammed Batur
ESErbil Seven
Erbil Seven
MUMeltem Tan Uygun
Meltem Tan Uygun
To evaluate the therapeutic effects of bakuchiol on clinical and histopathological outcomes in a rat model of corneal alkali burn. Corneal alkali burns were induced in the right eyes of 35 male Wistar rats, which were randomized into five groups: control, carbomer, steroid, 0.14 mg/g bakuchiol, and 0.28 mg/g bakuchiol. Examinations were performed under stereomicroscopy with intraperitoneal ketamine anesthesia on days 0, 3, 7, and 14 to assess corneal epithelial defects and opacity; on day 14, corneal neovascularization was additionally evaluated. After the final examination, the eyes were enucleated, and the corneas were processed for hematoxylin-eosin and immunohistochemical staining. Epithelial necrosis, inflammatory cell density, corneal hemorrhage, stromal edema, and staining intensity for VEGF and TNF-α were semi-quantitatively scored. Bakuchiol treatment, particularly at 0.28 mg/g, significantly reduced corneal opacity, neovascularization, hemorrhage, and stromal edema compared with the steroid-treated group. Bakuchiol demonstrated promising anti-inflammatory and anti-angiogenic effects and may represent a potential adjunctive treatment for corneal chemical injuries.

28 January 2024 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
SBSerhat Binici
Serhat Binici
MGMustafa Güven
Mustafa Güven
AÖABDULSELAM ÖZDEMİR
ABDULSELAM ÖZDEMİR
ZIZehra Akman ilik
Zehra Akman ilik
BDBirhan Demirhan
Birhan Demirhan
ÜIÜmit Haluk İlIklerden
Ümit Haluk İlIklerden

27 December 2023 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
NTNurşen Toprak
Nurşen Toprak
AYAdem Yokus
Adem Yokus
AGAli Mahir Gunduz
Ali Mahir Gunduz
FDFatma Durmaz
Fatma Durmaz
ZIZehra Akman ilik
Zehra Akman ilik